N-(6-(((6-(CYCLOPROPANECARBONYLAMINO)-4-(2-METHOXY-3-(1-METHYL-1,2,4-TRIAZOL-3-YL)ANILINO)PYRIDAZINE-3-CARBONYL)AMINO)CARBAMOYL)-5-(2-METHOXY-3-(1-METHYL-1,2,4-TRIAZOL-3-YL)ANILINO)PYRIDAZIN-3-YL)CYCLOPROPANECARBOXAMIDE
UNII KWY87QPS99
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(6-(((6-(cyclopropanecarbonylamino)-4-(2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino)pyridazine-3-carbonyl)amino)carbamoyl)-5-(2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino)pyridazin-3-yl)cyclopropanecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KWY87QPS99.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3097652-25-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C38H38N16O6 ZWPYWNKMDIIPIR-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(6-(((6-(cyclopropanecarbonylamino)-4-(2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino)pyridazine-3-carbonyl)amino)carbamoyl)-5-(2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino)pyridazin-3-yl)cyclopropanecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.